Tag: Thomas Frederickson

Preventing Opioid-Induced Respiratory Distress In An Outpatient Setting

by Thomas W. Frederickson, MD, MBA, FACP, SFHM, Medical Director, Hospital Medicine, CHI Health

Thomas W. Frederickson MD, FACP, SFHM, MBA discusses the deadly combination of opioids and benzodiazepines in hospitalized patients. Please click on the image to listen to an interview with Dr. Frederickson on YouTube.

With the increasing volume of procedures being moved to outpatient settings, procedures and processes need to be in place to make ensure patient safety.

The Society of Hospital Medicine has released a set of guidelines to reduce opioid-related adverse events in a clinical setting titled the Reducing Adverse Drug Events related to Opioids (RADEO) Implementation Guide. I had the pleasure of leading the expert panel tasked with developing the guide. The manual is designed as a resource to help clinicians successfully implement a quality improvement program.

In this article, I want to focus on some key precautions to take during procedures in the outpatient setting, as well as upon patient discharge.

Read the full article on Becker’s Hospital Review.

5 Key Steps to Assessing and Identifying At-Risk Patients for Respiratory Compromise

The cost of opioid-related adverse events, in terms of both human life and hospital expenses, remains at the forefront of the public eye. It has been estimated that yearly costs in the United States associated with opioid-related post-operative respiratory failure were estimated at $2 billion.

The Society of Hospital Medicine, which is the largest organization representing hospitalists and a resource for hospital medicine, recently released a comprehensive guide, “Reducing Adverse Drug Events Related to Opioids” (otherwise known as the RADEO guide).

To better understand the RADEO guide, the Physician-Patient Alliance for Health & Safety interviewed its lead author, Thomas W. Frederickson MD, FACP, SFHM, MBA. Continue reading “5 Key Steps to Assessing and Identifying At-Risk Patients for Respiratory Compromise”